Vaccine-Preventable Diseases

Top Story

ACIP recommends single-dose revaccination for infants born to HBV-infected mothers

February 22, 2017

The Advisory Committee on Immunization Practices voted today in favor of single-dose alternative to 3-dose revaccination for infants born to hepatitis B surface antigen-positive mothers who failed to respond to the initial hepatitis B vaccination series.

In a 13-1 vote, with one recusal, the committee approved the recommendation that HBsAg-negative infants with hepatitis B surface antibody levels <10 IU/mL should be revaccinated with a single dose of hepatitis B vaccine, followed by post-vaccination serologic testing 1-2 months later.

In the Journals

Smear-negative youth screened for TB reveal low risk of transmission in schools

February 21, 2017
Researchers in Italy found that the Mycoplasma tuberculosis transmission rate in school settings from smear-negative index cases were very low, particularly in those
In the Journals

Men-C-Con vaccine more economical vs. Men-4-Con vaccine in Quebec

February 20, 2017
Monovalent C meningococcal conjugate vaccine was a more economical option compared with a quadrivalent ACWY vaccine due to low epidemiologic factors for disease risk…
Eye on ID

‘Anti-vaxxers’: A menace to public health

Infectious Disease News, February 2017
Marjorie P. Pollack, MD; Donald Kaye, MD, MACP
Vaccines have been a wonderful addition to the medical armamentarium and have made major inroads in reducing morbidity and mortality due to infectious diseases. They…

Identifying and Addressing Vaccine Hesitancy

Pediatric Annals, April 2015, Volume 44 Issue 4
In the 20th century, the introduction of multiple vaccines significantly reduced childhood morbidity, mortality, and…
More »

Vaccines: April 2015

Keck School of Medicine of USC and Pediatric Annals

Vaccine refusal and hesitancy to vaccinate has been a growing problem in the past 2-3 decades. Perhaps victims of our…
More »
Meeting News Coverage

VIDEO: Flublok demonstrates superior efficacy over IIV

April 21, 2016
More »
In the Journals

Delaying Gardasil uptake, completion incurs infection, abnormalities

November 18, 2016
Delayed uptake and longer times between doses of HPV vaccine accrued increased rates of infection and cervical cytological abnormalities, per data…

In the Journals

Decline in pulmonary TB hospitalizations among children not associated with PCV

November 16, 2016
Researchers in South Africa found no temporal association between hospitalizations for children with culture-confirmed pulmonary tuberculosis and…


DNA-based Zika vaccine development continues after promising early data

November 10, 2016
PHILADELPHIA – The Wistar Institute recently hosted a Q&A discussion panel event during which researchers shared promising new developments…

In the Journals

Triggered vaccination campaigns could reduce size, severity of measles outbreaks

November 8, 2016
Supplemental vaccination campaigns triggered by measles outbreaks could significantly reduce incidence and prevent more severe outbreaks, with…

Apnea/bradycardia non-recurrent with DTwP vaccine in low-birth-weight infants

November 4, 2016
NEW ORLEANS – Immunization with diphtheria, tetanus and whole cell pertussis did not increase or cause recurrence risk for apnea/bradycardia in…

Search for RSV vaccine includes new target

November 4, 2016
A vaccine for respiratory syncytial virus, or RSV, has long remained out of reach for researchers, but a drug that takes aim at a novel target has…

Meeting NewsVideo

VIDEO: Researchers make progress in norovirus vaccine development

October 30, 2016
NEW ORLEANS — John J. Treanor, MD, chief of infectious diseases at the University of Rochester Medical Center, reviews several vaccine…

Meeting News

Fatal measles complication more common than previously understood

October 28, 2016
NEW ORLEANS — Subacute sclerosing panencephalitis — a 100% fatal complication of measles — occurs much more often than previously…

Meeting News

Priorix, M-M-R II exhibited similar safety, immune response during MMR vaccination

October 28, 2016
NEW ORLEANS – A measles, mumps and rubella vaccine developed by GlaxoSmithKline to have immune response rates and a safety profile similar to…

Officials say $1.5 billion needed to finish job of polio eradication

October 25, 2016
Finishing the job of eradicating polio will cost an additional $1.5 billion and will require enhanced vaccination and surveillance efforts in…

More Headlines »